Rowett Institute of Nutrition and Health; University of Aberdeen; Aberdeen, UK; Department of Microbiology & Alimentary Pharmabiotic Centre; University College Cork; Cork, Ireland.
Louvain Drug Research Institute; Université Catholique de Louvain; Brussels, Belgium.
Gut Microbes. 2014 Jan-Feb;5(1):74-82. doi: 10.4161/gmic.27252. Epub 2013 Dec 16.
It has become clear in recent years that the human intestinal microbiota plays an important role in maintaining health and thus is an attractive target for clinical interventions. Scientists and clinicians have become increasingly interested in assessing the ability of probiotics and prebiotics to enhance the nutritional status of malnourished children, pregnant women, the elderly, and individuals with non-communicable disease-associated malnutrition. A workshop was held by the International Scientific Association for Probiotics and Prebiotics (ISAPP), drawing on the knowledge of experts from industry, medicine, and academia, with the objective to assess the status of our understanding of the link between the microbiome and under-nutrition, specifically in relation to probiotic and prebiotic treatments for under-nourished individuals. These discussions led to four recommendations: (1) The categories of malnourished individuals need to be differentiated To improve treatment outcomes, subjects should first be categorized based on the cause of malnutrition, additional health-concerns, differences in the gut microbiota, and sociological considerations. (2) Define a baseline "healthy" gut microbiota for each category Altered nutrient requirement (for example, in pregnancy and old age) and individual variation may change what constitutes a healthy gut microbiota for the individual. (3) Perform studies using model systems to test the effectiveness of potential probiotics and prebiotics against these specific categories These should illustrate how certain microbiota profiles can be altered, as members of different categories may respond differently to the same treatment. (4) Perform robust well-designed human studies with probiotics and/or prebiotics, with appropriate, defined primary outcomes and sample size These are critical to show efficacy and understand responder and non-responder outcomes. It is hoped that these recommendations will lead to new approaches that combat malnutrition. This report is the result of discussion during an expert workshop titled "How do the microbiota and probiotics and/or prebiotics influence poor nutritional status?" held during the 10th Meeting of the International Scientific Association for Probiotics and Prebiotics (ISAPP) in Cork, Ireland from October 1-3, 2012. The complete list of workshop attendees is shown in Table 1.
近年来,人们越来越清楚地认识到,人类肠道微生物群在维持健康方面发挥着重要作用,因此成为临床干预的一个有吸引力的目标。科学家和临床医生越来越有兴趣评估益生菌和益生元增强营养不良儿童、孕妇、老年人和与非传染性疾病相关营养不良个体营养状况的能力。国际益生菌和益生元科学协会(ISAPP)举办了一次研讨会,借鉴了来自工业、医学和学术界的专家的知识,旨在评估我们对微生物组与营养不良之间关系的理解现状,特别是与益生菌和益生元治疗营养不良个体有关的关系。这些讨论产生了四项建议:
为了改善治疗效果,首先应根据营养不良的原因、其他健康问题、肠道微生物群的差异和社会学考虑对受试者进行分类。
改变营养需求(例如,在怀孕期间和老年时)和个体差异可能会改变个体健康肠道微生物群的构成。
这些研究应说明如何改变某些微生物组谱,因为不同类别的成员可能对相同的治疗有不同的反应。
这些对于证明疗效以及了解应答者和非应答者的结果至关重要。
希望这些建议将导致对抗营养不良的新方法。本报告是在 2012 年 10 月 1 日至 3 日于爱尔兰科克举行的题为“微生物组和益生菌和/或益生元如何影响不良营养状况?”的专家研讨会上讨论的结果。研讨会的完整与会者名单见附表 1。